Acute Kidney Injury in stable COPD and at exacerbation
File(s)
Author(s)
Type
Journal Article
Abstract
Background: While acute kidney injury (AKI) alone is associated with increased mortality, the incidence of hospital admission with acute kidney injury (AKI) among stable and exacerbating chronic obstructive pulmonary disease (COPD) patients and the effect of concurrent AKI at COPD exacerbation on mortality is not known.
Methods: 189,561 individuals with COPD were identified from the Clinical Practice Research Datalink (CPRD). Using Poisson and logistic regression we explored which factors predicted admission for acute kidney injury (AKI) (identified in Hospital Episode Statistics (HES)) in this COPD cohort, and concomitant AKI at a hospitalisation for COPD exacerbation. Using survival analysis we investigated the effect of concurrent AKI at exacerbation on mortality (n=36,107), and identified confounding factors.
Results: The incidence of AKI in the total COPD cohort was 128 per 100,000 person-years. The prevalence of concomitant AKI at exacerbation was 1.9% and the mortality rate in patients with AKI and an exacerbation was 521 per 1,000 person-years. Male gender, older age, and lower glomerular filtration rate predicted higher risk of AKI or death. There was a 1.80 fold (95%CI:1.61,2.03) increase in adjusted mortality within the first 6 months post COPD exacerbation in patients suffering AKI and COPD exacerbation compared to those who were AKI-free.
Conclusion: In comparison to previous studies on general populations and hospitalisations, the incidence and prevalence of AKI is relatively high in COPD patients. Coexisting AKI at exacerbation is prognostic of poor outcome.
Methods: 189,561 individuals with COPD were identified from the Clinical Practice Research Datalink (CPRD). Using Poisson and logistic regression we explored which factors predicted admission for acute kidney injury (AKI) (identified in Hospital Episode Statistics (HES)) in this COPD cohort, and concomitant AKI at a hospitalisation for COPD exacerbation. Using survival analysis we investigated the effect of concurrent AKI at exacerbation on mortality (n=36,107), and identified confounding factors.
Results: The incidence of AKI in the total COPD cohort was 128 per 100,000 person-years. The prevalence of concomitant AKI at exacerbation was 1.9% and the mortality rate in patients with AKI and an exacerbation was 521 per 1,000 person-years. Male gender, older age, and lower glomerular filtration rate predicted higher risk of AKI or death. There was a 1.80 fold (95%CI:1.61,2.03) increase in adjusted mortality within the first 6 months post COPD exacerbation in patients suffering AKI and COPD exacerbation compared to those who were AKI-free.
Conclusion: In comparison to previous studies on general populations and hospitalisations, the incidence and prevalence of AKI is relatively high in COPD patients. Coexisting AKI at exacerbation is prognostic of poor outcome.
Date Issued
2015-09-28
Date Acceptance
2015-07-24
Citation
International Journal of COPD, 2015, 10 (1), pp.2067-2077
ISSN
1178-2005
Publisher
Dove Medical Press
Start Page
2067
End Page
2077
Journal / Book Title
International Journal of COPD
Volume
10
Issue
1
Copyright Statement
© 2015 Barakat et al. This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License.
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
License URL
Publication Status
Published